FDA Approved Clinical Trials for Lagundi as COVID-19 Treatment

The country's Food and Drug Administration (FDA) has approved the clinical trials for one of the Philippines most popular herbal medicine, "Lagundi" as a probable treatment for Coronavirus Disease (COVID-19).

Department of Science and Technology (DOST) Secretary Fortunato dela Peña confirmed on Saturday, August 29, that the Philipine General Hospital (PGH) will lead the clinical trials for Lagundi as a possible cure to the deadly COVID-19 which wreaked havoc not only in the Philippines but also around the world.

“Iyon pong sa lagundi, ang good news po ay naaprubahan na ng FDA ang clinical trials. So ito lang early this week po naaprubahan, so hopefully, hindi ko pa natsi-check ngayong araw na ito -- ay nagsimula na, at ito ay sa PGH gagawin,” he said.

The DOST official said that lagundi may help ease Covid-19 symptoms like cough and sore throat. The herbal plants was already proven effective to fight against ordinary cough and colds.

“Gaya nga ng nasabi ko noong una, ang hangad natin diyan ay ma-address iyong mga symptoms katulad ng ubo, lagnat at iyang mga sore throat kasi malaking bagay kung giginhawa ang ating pasyente na mild cases diyan sa mga symptoms na iyan,” Dela Peña said.

(Our aim is to address the Covid-19 symptoms like cough, fever and sore throat, because it would be a big help if those with mild symptoms will feel better.)

“Titignan din natin kung ano ba ang probability na sila ay bababa ba iyong probability na magpo-progress sila into moderate and severe cases kung bibigyan iyang mga gamot na iyan -- lagundi,” he added.

(We will also see whether those with mild symptoms will recover or progress to moderate and severe cases when given lagundi.)

Based upon the initial report of the PGH in coordination with DOST, there are around 200 Covid-19 patients who will join the clinical trials using the herbal plants, lagundi.

Identified participants are patients with mild symptoms and admitted at the Quezon Institute quarantine center, Sta. Ana Hospital, and Philippine National Police-National Capital Region (PNP-NCR) community quarantine center.

Source: SunStar News

FDA Approved Clinical Trials for Lagundi as COVID-19 Treatment FDA Approved Clinical Trials for Lagundi as COVID-19 Treatment Reviewed by Phil Newsome on August 29, 2020 Rating: 5
Powered by Blogger.